Navigation Links
Data From Largest Stroke Prevention Trial in Atrial Fibrillation To Premiere at European Society of Cardiology Congress
Date:8/25/2009

RIDGEFIELD, Conn., Aug. 25 /PRNewswire/ -- Results of the Phase III RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared to Dabigatran)(1) study will be presented at the European Society of Cardiology (ESC) Congress in Barcelona on Sunday, Aug. 30. The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate, against the current standard therapy, warfarin, for the prevention of stroke in patients with atrial fibrillation (AF).(1)

Atrial fibrillation affects approximately 2.3 million Americans(2) and can increase the risk of stroke five-fold.(3) Top-line findings from the 18,113 patient RE-LY study(1) will be featured in an ESC press briefing on Sunday, Aug. 30 at 8:00 a.m. CEST, with the full results presented in a "Hot-Line" session at 11:00 a.m. CEST. The study will also be simultaneously published in a leading peer-reviewed medical journal.

Dabigatran etexilate is an investigational oral anticoagulant in Phase III development for stroke prevention in AF(1) and several other therapeutic areas, including prevention of atherothrombotic events in patients with acute coronary syndrome,(4) as well as primary prevention, (5),(6),(7) secondary prevention(8) and treatment of venous thromboembolism.(9) Dabigatran etexilate is not yet approved by the U.S. Food and Drug Administration.

In addition to the primary findings, a RE-LY sub-analysis of treatment naive patients will also be presented during a "Clinical Trial Update" session on Wednesday, Sept. 2 at 8:00 a.m. CEST.

About RE-LY: The largest AF outcomes trial to date

RE-LY was a global, Phase III, randomized trial of 18,113 patients(1) enrolled in more than 900 centers in 44 countries,(1) investigating whether dabigatran etexilate (two blinded doses) was as effective as well-con
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. CTMM Becomes One of the Worlds Largest Public-Private Partnerships in Translational Medical Research
2. PSA Screening Cuts Deaths by 20%, Says Worlds Largest Prostate Cancer Study
3. Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
4. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
5. Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD
6. The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications
7. Safety and Efficacy Results Presented From Largest Prospective Controlled Clinical Study of Ulcerative Colitis
8. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
9. Universite de Montreal Researchers Simulate Worlds Largest Heart Model Using SGI Technology
10. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
11. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ... and audio webcast to discuss financial results for the second ... July 31, 2014 at 4:30 p.m. ET. ... July 31, 2014 Time: 4:30 PM ET Listen via Internet: ... A webcast replay will be available on the ...
(Date:7/28/2014)... July 28, 2014  Dignity Health St. Mary,s ... the Get With The Guidelines®-Stroke Silver-Plus Quality Achievement ... by the American Heart Association/American Stroke Association for ... number four cause of death and a leading ... United States , according to the American ...
(Date:7/28/2014)... Inc. (NASDAQ: ANTH ), today announced financial results ... 2014. Net loss for the three months ... million for the same period in 2013. The decrease in ... interest expense in the current period.  Net ... $15.2 million, compared with net loss of $15.9 million for ...
Breaking Medicine Technology:Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 2Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 3Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 4Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 5Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 6Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update 7
(Date:7/28/2014)... 29, 2014 Treat skin to a true ... Beauty®. , Today and tomorrow only (while supplies last), take ... cleanser is ideal for two specific users: , 1) those ... and bacteria free, and , 2) aging skin to help ... Kathy Heshelow, founder of Sublime Beauty®. , Those with oily ...
(Date:7/28/2014)... blood cell development have spread from Africa into nearly ... new study led by King,s College London. The international ... for the origin of changes in a key regulator ... haemoglobin is normally found in fetuses and infants, but ... to keep making it as adults experience milder symptoms ...
(Date:7/28/2014)... July 29, 2014 A leading proposal ... Security disability trust fund by reallocating payroll taxes has ... poll by The Senior Citizens League (TSCL) . ... shifting revenues from the Social Security retirement trust fund ... fix the disability program’s financing. “TSCL believes this ‘band ...
(Date:7/28/2014)... 29, 2014 NAPW honors ... County Hospital Center, as a 2014 Professional Woman of ... distinction for leadership in community health. As the largest, ... virtually every industry and profession, the National Association of ... with over 600,000 members and nearly 300 Local Chapters. ...
(Date:7/28/2014)... have long known that they monopolize large amounts of ... cells are also characterized by a series of features ... ordered set. Researchers are calling this behavior "mesenchymal," and ... Meylan,s research team was able to demonstrate that the ... result from the same mechanism, at least in ...
Breaking Medicine News(10 mins):Health News:Clear, Clean Skin With the New Salicylic Wash from Sublime Beauty®; Enlivens Skin, Unclogs Pores 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 2Health News:Study tracks worldwide spread of beneficial blood cell gene variant 3Health News:The Senior Citizens League Finds No Support Among Seniors for Likely Disability Trust Fund Fix 2Health News:The Senior Citizens League Finds No Support Among Seniors for Likely Disability Trust Fund Fix 3Health News:National Association of Professional Women Announces Pamela A. Schulters, Head Nurse at Kings County Hospital Center, a 2014 Professional Woman of the Year 2Health News:Cancer: Tumors absorb sugar for mobility 2
... incidents at the nation’s hospitals rose three percent over ... hospitals had a 40 percent lower rate of medical ... the largest annual study of patient-safety issued today by ... ,The HealthGrades study of 40.56 million Medicare hospitalization ...
... figure out the words' meaning for themselves, research by a ... an undergraduate student in the John Hopkins University and who ... by inference is more powerful for 3-year-olds than just being ... that is particularly exciting about the work Meredith is doing ...
... A homeopathic treatment for cancer is under trial at a ... it would pass muster in the next six months., ... homeopathic medicine have already begun in the United States and ... its efficacy," Dr Susanta K Banerjee, a professor of haematology ...
... the state children’s health insurance program (SCHIP), teens ... eliminated and more preventive care is received. This ... their health care providers about guns, smoking, drugs, ... their long-term health. ,"Adolescents have the ...
... For the first time ever, a team of Toronto ... tests //to screen high-risk pregnant mothers for placental damage. ... be reassured that their placenta is formed and functioning ... tests are done early enough, at 16 to 23 ...
... endogenous pain-inhibitory function and increases spontaneous pain in women//. ... in chronic pain, according to a study published in ... ,The study, conducted by Michael T. Smith, PhD, and ... females, who were studied polysomnographically for seven nights. On ...
Cached Medicine News:Health News:Hospital Errors Rise 3 Percent -- HealthGrades Patient-safety Study 2Health News:Hospital Errors Rise 3 Percent -- HealthGrades Patient-safety Study 3Health News:Learning Words by Inference More Powerful for Toddlers 2Health News:Teens Get Needed Access to Care With State Health Insurance 2Health News:Teens Get Needed Access to Care With State Health Insurance 3Health News:New Placenta Screening for High-risk Pregnancies 2Health News:New Study in SLEEP Finds That Sleep Disturbance Increases Spontaneous Pain in Women 2
Codman periosteal elevators, sharp, length 8" (203 mm), blade width 3/16" (5 mm)....
Langenbeck periosteal elevators, wide, blade width 11/16" (17 mm), length 7 1/2" (191 mm)....
Iowa University periosteal elevator, blade width 11/16" (17 mm), length 7 1/4" (184 mm)....
Cushing-Hopkins periosteal elevator, Gutsch handle, blade width 7/16" (11 mm), length 7 5/8" (194 mm)....
Medicine Products: